title: Hapten-induced contact hypersensitivity, autoimmune reactions, and tumor regression: plausibility of mediating antitumor immunity.
abstract: Haptens are small molecule irritants that bind to proteins and elicit an immune response. Haptens have been commonly used to study allergic contact dermatitis (ACD) using animal contact hypersensitivity (CHS) models. However, extensive research into contact hypersensitivity has offered a confusing and intriguing mechanism of allergic reactions occurring in the skin. The abilities of haptens to induce such reactions have been frequently utilized to study the mechanisms of inflammatory bowel disease (IBD) to induce autoimmune-like responses such as autoimmune hemolytic anemia and to elicit viral wart and tumor regression. Hapten-induced tumor regression has been studied since the mid-1900s and relies on four major concepts: (1) ex vivo haptenation, (2) in situ haptenation, (3) epifocal hapten application, and (4) antigen-hapten conjugate injection. Each of these approaches elicits unique responses in mice and humans. The present review attempts to provide a critical appraisal of the hapten-mediated tumor treatments and offers insights for future development of the field.
authors.affiliation: Immunology and Microbial Pathogenesis Graduate Program, Thomas Jefferson University, Philadelphia, PA 19107, USA.
authors.forename: Dan A
authors.initials: DA
authors.lastname: Erkes
authors.affiliation: Division of Solid Tumor, Department of Medical Oncology, Thomas Jefferson University, Curtis Building, Suite 1024B, 1015 Walnut Street, Philadelphia, PA 19107, USA.
authors.forename: Senthamil R
authors.initials: SR
authors.lastname: Selvan
mesh_terms: D000818:Animals; D000941:Antigens / Q000737:chemistry / Q000276:immunology; D000970:Antineoplastic Agents / Q000737:chemistry / Q000627:therapeutic use*; D015551:Autoimmunity; D016207:Cytokines / Q000096:biosynthesis; D017449:Dermatitis, Allergic Contact / Q000276:immunology* / Q000473:pathology; D006241:Haptens / Q000737:chemistry / Q000276:immunology*; D006801:Humans; D018796:Immunoconjugates / Q000737:chemistry / Q000627:therapeutic use*; D007075:Immunoglobulin M / Q000096:biosynthesis; D051379:Mice; D009369:Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D012867:Skin / Q000276:immunology / Q000473:pathology; D013601:T-Lymphocytes / Q000276:immunology; D047368:Tumor Burden / Q000187:drug effects
chemical_list: D000941:Antigens; D000970:Antineoplastic Agents; D016207:Cytokines; D006241:Haptens; D018796:Immunoconjugates; D007075:Immunoglobulin M